TITLE

Unfractioned Heparin in the Therapy of Patients With Highly Active Inflammatory Bowel Disease

AUTHOR(S)
Folwaczny, C.; Wiebecke, B.; Loeschke, K.
PUB. DATE
June 1999
SOURCE
American Journal of Gastroenterology;Jun1999, Vol. 94 Issue 6, p1551
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: Unfractioned heparin reportedly improves severe ulcerative colitis and Crohn's disease, but most of the few observations made have been published as abstracts. This prospective study evaluated whether heparin results in improvement of disease activity in patients with highly active, refractory ulcerative colitis or Crohn's disease. METHODS: Thirteen patients with ulcerative colitis and four patients with Crohn's disease received continuous intravenous heparin, aiming at a partial thromboplastin time of about 60 s for 2 wk. The following 6 wk, patients injected 12,500 units of heparin twice daily. All patients received sulphasalzine (1g t.i.d.). Clinical and laboratory data were assessed weekly during the first month of treatment and every other week thereafter. RESULTS: A significant decline of clinical activity (p = 0.0059), C-reactive protein (p = 0.0119), and erythrocyte sedimentation rate (p = 0.0096) was observed in the ulcerative colitis patients. In Crohn's disease clinical activity and laboratory values remained unchanged. Seven patients with ulcerative colitis but none of the Crohn's disease patients achieved complete remission after an average of 4 wk. In ulcerative colitis the histology (p = 0.0431) but not the endoscopic score (p = 0.1088) improved significantly. In one patient with ulcerative colitis, massive colonic bleeding was observed on day 11 of the study. CONCLUSIONS: These data are further evidence of a beneficial effect of unfractioned heparin in the therapy of patients with highly active ulcerative colitis. Because of possible serious bleeding, intravenous heparin should be administered in hospitalized patients only.
ACCESSION #
16444838

 

Related Articles

  • Non-TNF blocker for colitis, Crohn disease.  // Clinical Advisor;Jan2015, Vol. 18 Issue 1, p40 

    No abstract available.

  • And So the Worm Turns.  // Medical Update;Nov99, Vol. 23 Issue 5, p3 

    Focuses on the research at the University of Iowa which stated that modern advances in hygiene may be contributing to the increase of Crohn's disease and ulcerative colitis in industrialized countries.

  • Prognosis of colonic Crohn's disease. Elliott, P.R.; Ritchie, J.K.; Lennard-Jones, J.E. // British Medical Journal (Clinical Research Edition);7/20/1985, Vol. 291 Issue 6489, p178 

    Reports the prognosis of colonic Crohn's disease. Comparisons between Crohn's disease and ulcerative colitis; Information on the surgical treatment of Crohn's disease; Features of regional enteritis.

  • Breakfast and Crohn's disease-II. Archer, L.N.J.; Harvey, Richard F. // British Medical Journal;8/19/1978, Vol. 2 Issue 6136, p540 

    Part II. Examines the breakfast habits of patients with Crohn's disease and ulcerative colitis in Great Britain. Importance of dietary factors in the aetiology of Crohn's disease; Emphasis on cornflake eating of patients; Absence of evidence on the association of diseases with cornflakes...

  • An Introduction to Crohn's Disease and Ulcerative Colitis.  // Nutrition Health Review: The Consumer's Medical Journal;2010, Issue 104, p8 

    An excerpt from the book "Living with Crohn's and Colitis," by Jessica Black and Dede Cummings is presented.

  • Investigation of inheritance of chronic inflammatory bowel disease by complex segregation analysis. Orholm, Marianne; Iselius, Lennart; Sorensen, Thorkild I.A.; Munkholm, Pia; Langholz, Ebbe; Binder, Vibeke // BMJ: British Medical Journal (International Edition);1/2/93, Vol. 306 Issue 6869, p20 

    Investigates the mode of inheritance of ulcerative colitis and Crohn disease by complex segregation analysis. Occurrence of chronic inflammatory bowel disease; Assessment on the patterns of segregation with the computer program POINTER; Role of gene in ulcerative colitis.

  • Clinical Trials for Digestive Diseases. SerVaas, Cory // Medical Update;Apr2002, Vol. 27 Issue 10, p7 

    Provides information on clinical trials in the diagnosis and treatment of ulcerative colitis and Crohn's disease by researchers from around the U.S.

  • Oral Delayed-Release Mesalazine: A Review of its Use in Ulcerative Colitis and Crohn's Disease. Prakash, A.; Markham, A. // Drugs;Mar1999, Vol. 57 Issue 3, p383 

    Oral delayed-release mesalazine is an enteric-coated formulation which releases mesalazine in the terminal ileum and colon. Up to 74% of patients with mild to moderately active ulcerative colitis experience endoscopic or symptomatic improvement (including remission) or both when treated with...

  • Family Occurences of Ulcerative Colitis, Regional Enteritis, and Ileocolitis. Kirsner, Joseph B.; Spencer, Jean A. // Annals of Internal Medicine;Aug63, Vol. 59 Issue 2, p133 

    Examines the family incidence of ulcerative colitis, regional enteritis and ileocolitis in Chicago, Illinois. Distribution patterns of ulcerative colitis, regional enteritis and ileocolitis in families with multiple affected members; Numbers of affected family members per proband.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics